The fact that CSF1R mediates microglia proliferation only at late stages of ALS disease is important in the present study, since the beneficial effects of GW2580 on motor function were already evident at the electrophysiological level from week 10–12, when CSF1 was not yet induced in the CNS. This evidence concerns the gene CSF1 and amyotrophic lateral sclerosis.